Screening for lung disease in rheumatoid arthritis and scleroderma
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study tests a new way to help doctors spot early signs of lung disease in people with rheumatoid arthritis or scleroderma. It uses a computer tool during regular visits to ask about symptoms and decide if a lung test is needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have rheumatoid arthritis or scleroderma
- You have never been diagnosed with interstitial lung disease
- You have not had a lung CT scan or breathing test in the last 2 years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to find early signs of lung scarring (interstitial lung disease) in people with rheumatoid arthritis or scleroderma using a blood test and a lung ultrasound. It may help detect lung problems earlier, when treatment could be more effective.
This study looks for early lung scarring in people who have rheumatoid arthritis. It may help find a serious lung condition earlier so doctors can watch or treat it sooner.
This trial studies lung scans (HRCT) from patients with rheumatoid arthritis, interstitial lung disease, or connective tissue disease to better understand lung involvement. If you have one of these conditions and have had a lung CT, you may be able to help.
This study helps doctors identify early signs of lung scarring (fibrosis) in patients with autoimmune diseases like scleroderma, rheumatoid arthritis, and Sjögren's syndrome. By catching this early, researchers hope to better understand and treat these complications.
This study uses CT scans and blood tests to look for lung signs related to rheumatoid arthritis. It aims to find lung issues early, which may help in managing the disease better.
This study looks at using chest CT scans to help predict how lung disease from scleroderma (SSc-ILD) may progress. It may help doctors better understand your condition.
Hear when a new Rheumatoid Arthritis (RA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.